%0 Meta-Analysis
%T Efficacy and safety of magnetic resonance-guided focused ultrasound for the treatment of osteoid osteoma: A systematic review and meta-analysis.
%A Hu R
%A He P
%A Tian X
%A Guan H
%J Eur J Radiol
%V 166
%N 0
%D 2023 Sep 22
%M 37523874
%F 4.531
%R 10.1016/j.ejrad.2023.111006
%X <B>OBJECTIVE: </B>Magnetic resonance-guided focused ultrasound (MRgFUS) is a novel noninvasive interventional technique for osteoid osteoma (OO). The purpose of this study was to evaluate the efficacy and safety of MRgFUS in the treatment of OO through a systematic review and meta-analysis of pain scores and post-treatment adverse events before and after MRgFUS treatment.<BR><B>METHODS: </B>A comprehensive literature search of PubMed, Embase, Web of science, and Cochrane Library databases was conducted to screen the study literature based on inclusion and exclusion criteria to extract and analyze pre- and post-treatment pain score data, success rates (complete pain relief with no recurrence until the last follow-up), recurrence rates, secondary intervention rates, and complications to evaluate the efficacy and/or safety of MRgFUS for OO.<BR><B>RESULTS: </B>A total of 113 studies published between 2012 and 2022were collected, resulting in a total sample size of 353 patients. The majority of the studies were prospective and had a follow-up period of 4 weeks or more, and overall, the quality of evidence ranged from low to high. Pain scores at 1 week and 1 month after the merger were 0.62 (9.5% CI:0.28-0.96) and 0.37 (9.5% CI:0.07-0.68), respectively. The success rate of the combination was 92.8% (95% CI: 89.8%-95.7%), the incidence of minor complications (thermal injury at the ablation site) was 0.85%, and no major complications were recorded in any of the included literature.<BR><B>CONCLUSIONS: </B>MRgFUS is an effective procedure that is able to treat pain for patients with OO with satisfying efficacy and safety.<BR><B>UNASSIGNED: </B>No.CRD42023415573.